Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG booster before typhoid Vi vaccination in healthy adult travelers
NL-OMON37465Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of bcg vaccine and typhoid polysaccharide vaccine in typhoid fever, Tuberculosis (TB) and leprosy (HD) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Cytokine production against Salmonella typhi Vi antigen and Antibody titers against Salmonella typhi Vi antigen. Started Jul 2013; status: recruiting.
02
Drugs
bcg vaccinetyphoid polysaccharide vaccine
03
Conditions
typhoid feverTuberculosis (TB)leprosy (HD)
Beyond the preview
Go deeper on NL-OMON37465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37465.